STOCK TITAN

Encompass Health (EHC) CFO Coltharp sells 18,869 shares at $125.38 average

(Very High)
(Negative)
Form Type
4

Rhea-AI Filing Summary

Encompass Health Corp executive Douglas E. Coltharp, EVP & Chief Financial Officer, reported selling 18,869 shares of Encompass Health common stock on 2026-08-10 in a sale classified as an open market or private transaction at a weighted average price of $125.38 per share, with individual prices ranging from $125.03 to $125.69. Following this transaction, he directly holds 50,508 shares and also reports indirect holdings through irrevocable trusts and a spouse.

Positive

  • None.

Negative

  • None.

Insights

Analyzing...

Insider COLTHARP DOUGLAS E
Role EVP & Chief Financial Officer
Sold 18,869 shs ($2.37M)
Type Security Shares Price Value
Sale Encompass Health Common Stock F1 18,869 $125.38 $2.37M
holding Encompass Health Common Stock -- -- --
holding Encompass Health Common Stock -- -- --
holding Encompass Health Common Stock -- -- --
Holdings After Transaction: Encompass Health Common Stock — 50,508 shares (Direct); Encompass Health Common Stock — 27,480 shares (Indirect, By irrevocable trust); Encompass Health Common Stock — 125,631 shares (Indirect, By irrevocable trust for the benefit of children); Encompass Health Common Stock — 37,749 shares (Indirect, By spouse)
Footnotes (1)
  1. F1. This per share price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $125.03 to $125.69, inclusive. The reporting person undertakes to provide to Encompass Health Corporation, any of its security holders, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within this range.
Shares sold 18,869 shares Common stock sale by CFO on 2026-08-10
Weighted average sale price $125.38 per share Weighted average price for 18,869 shares sold, with trades from $125.03 to $125.69
Direct holdings after transaction 50,508 shares Direct Encompass Health common stock held by CFO after sale
Indirect holdings – irrevocable trust 27,480 shares Shares held indirectly by irrevocable trust
Indirect holdings – children’s trust 125,631 shares Shares held indirectly by irrevocable trust for benefit of children
Indirect holdings – spouse 37,749 shares Shares held indirectly by spouse
Price range of sales $125.03 to $125.69 per share Range of prices for the multiple transactions comprising the reported sale
weighted average price financial
"This per share price is a weighted average price."
Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.
open market or private transaction financial
"Sale in open market or private transaction"
irrevocable trust financial
"nature_of_ownership: By irrevocable trust"
An irrevocable trust is a legal arrangement where an owner transfers assets into a separate entity managed by a trustee and gives up the power to modify or reclaim those assets. For investors it matters because putting stock or other holdings into such a trust can change who controls and benefits from the assets, affect taxes and creditor protection, and influence how easy it is to sell or value those holdings—like placing valuables in a locked safe overseen by someone else.

FAQ

What insider transaction did Encompass Health (EHC) report for CFO Douglas Coltharp?

Encompass Health (EHC) reported that CFO Douglas E. Coltharp sold 18,869 shares of common stock on 2026-08-10. The sale was reported as an open market or private transaction at a weighted average price of $125.38 per share.

At what price did the Encompass Health (EHC) CFO sell his shares?

The CFO’s reported sale used a weighted average price of $125.38 per share. A footnote explains the 18,869 shares were sold in multiple trades at prices ranging from $125.03 to $125.69 per share, inclusive.

How many Encompass Health (EHC) shares does the CFO hold directly after the Form 4 sale?

After the reported sale, CFO Douglas E. Coltharp directly holds 50,508 Encompass Health common shares. Additional shares are reported as indirectly owned through irrevocable trusts and by his spouse, each listed separately in the ownership table.

What indirect Encompass Health (EHC) share holdings are reported for the CFO?

Indirect holdings reported include 27,480 shares held by an irrevocable trust, 125,631 shares by an irrevocable trust for the benefit of children, and 37,749 shares held by his spouse. Each position is disclosed as indirect ownership on the Form 4.

Was the Encompass Health (EHC) CFO sale tied to a Rule 10b5-1 trading plan?

The filing does not indicate that the reported sale was made under a Rule 10b5-1 trading plan. The document-level checkbox is shown as false, and the footnotes describe pricing details but do not reference any trading plan arrangement.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
COLTHARP DOUGLAS E

(Last)(First)(Middle)
9001 LIBERTY PARKWAY

(Street)
BIRMINGHAM ALABAMA 35242

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
Encompass Health Corp [ EHC ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
EVP & Chief Financial Officer
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
08/10/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Encompass Health Common Stock08/10/2026S18,869D$125.38(1)50,508D
Encompass Health Common Stock27,480IBy irrevocable trust
Encompass Health Common Stock125,631IBy irrevocable trust for the benefit of children
Encompass Health Common Stock37,749IBy spouse
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. This per share price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $125.03 to $125.69, inclusive. The reporting person undertakes to provide to Encompass Health Corporation, any of its security holders, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within this range.
Remarks:
/s/ Patrick Darby, attorney-in-fact for Mr. Coltharp08/11/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)